Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-12-16

Clinical Trial Update: A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

A multicenter randomized trial comparing chemotherapy plus an unspecified PD-1 inhibitor to concurrent chemoradiotherapy in postoperative cervical cancer patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PD-1 inhibitor (unspecified)

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Cervical Cancers | Phase 2, Phase 3 | Status: WITHDRAWN